Renal accumulation and excretion of radioiodinated 3-iodo-α-methyl-L- tyrosine

Annals of Nuclear Medicine

Volumn 18, Issue 3, 2004, Pages 263-270

  Shikano, Naoto ^a   Kawai, Keiichi ^b   Nakajima, Syuichi ^b   Nishii, Ryuichi ^c   Flores II, Leo Garcia ^c   Kubodera, Akiko ^d   Kubota, Nobuo ^a   Ishikawa, Nobuyoshi ^a   Saji, Hideo ^e  

^a IBARAKI PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e KYOTO UNIVERSITY   (Japan)

Author keywords

3 iodo methyl L tyrosine; Amino acid transport; Artificial amino acid; Renal cortex

Indexed keywords

2 AMINOBICYCLO[2.2.1]HEPTANE 2 CARBOXYLIC ACID; 3 IODO ALPHA METHYLTYROSINE; ETACRYNIC ACID; FUROSEMIDE; IODINE 123; IODINE 125; IODOTYROSINE; MARKER; METIROSINE; PROBENECID; SODIUM; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ANIMAL CELL; APICAL MEMBRANE; ARTICLE; AUTORADIOGRAPHY; BRAIN FUNCTION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DOG; DOSE TIME EFFECT RELATION; DRUG DISTRIBUTION; DRUG EXCRETION; EPITHELIUM CELL; FECES ANALYSIS; HUMAN; HUMAN CELL; IN VIVO STUDY; INHIBITION KINETICS; ISOTOPE LABELING; KIDNEY CONCENTRATING CAPACITY; KIDNEY CORTEX; KIDNEY METABOLISM; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; LIPOPHILICITY; MOUSE; NONHUMAN; PANCREAS FUNCTION; PARTITION COEFFICIENT; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; RADIOIODINATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE; TUMOR DIAGNOSIS; URINARY EXCRETION; WHOLE BODY AUTORADIOGRAPHY;

EID: 3142550611     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02985009     Document Type: Article

References (26)

1. Kawai K, Fujibayashi Y, Saji H, Yonekura Y, Konishi J, Kubodera A, et al. A strategy for study of cerebral amino acid transport using iodine-123-labeled amino acid radiopharmaceutical: 3-iodo-alpha-methyl-[-tyrosine. J Nucl Med 1991; 32: 819-824.
2. 123I-3-iodo-alpha-methyl-L-tyrosine. Ann Nucl Med 1992; 6: 169-175.
3. 123I-3-iodo-α-methyl-L-tyrosine and preliminary kinetic analysis. Ann Nucl Med 1995; 9: 47-50.
4. Biersack HJ, Coenen HH, Stoecklin G, Reichmann K, Bockische A, et al. Imaging of brain tumors with L-3-[I123]iodo-α-methyl tyrosine and SPECT. J Nucl Med 1989; 30: 110-112.
5. Kuwert T, Woesler B, Morgenroth C, Lerch H, Schafers M, Palkovic S, et al. Diagnosis of recurrent glioma with SPECT and iodine-123-α-methyl tyrosine. J Nucl Med 1998; 39: 23-27.
6. Jager PL, Franssen EJF, Kool W, Szabo BG, Hoeckstra HJ, Groen HJM, et al. Feasibility of tumor imaging using L-3-[iodine-123]-iodo-alpha-methyl-tyrosine in extracranial tumors. J Nucl Med 1998; 39: 1736-1743.
7. 123I]Iodo-α-methyl- L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 2002; 29: 625-631.
8. Shikano N, Kawai K, Flores II LG, Nishii R, Kubota N, Ishikawa N, et al. An artificial amino acid 4-iodo-L-metatyrosine: Biodistribution and excretion via kidney. J Nucl Med 2003; 44: 625-631.
9. Flores II LG, Kawai K, Nakagawa M, Shikano N, Jinnouchi S, Tamura S, et al. A new radiopharmaceutical for the cerebral dopaminergic presynaptic function: 6-radioiodinated L-meta-tyrosine. J Cereb Blood Flow Metab 2000; 20: 207-212.
10. Brazeau P. Inhibitors of tubular transport of organic compounds. In: The Pharmacologic Basis of Therapeutics, Goodman L, Gilman A (eds), New York; MacMillan Publishing Co., Inc., 1975: 862-863.
11. Fritzberg AR, Kasina S, Eshima D, Johnson DL. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement. J Nucl Med 1986; 27: 111-116.
12. Winchell SH, Baldwin RM, Lin TH. Development of I-123-labeled amines for brain studies: localization of I-123-iodophenylalkyl amines in rat brain. J Nucl Med 1980; 21: 940-946.
13. Cooper JR, Bloom FE, Roth RH. Catecholamine. I. General aspects. In: The biochemical basis of neuropharmacology, 5th ed, New York; Oxford University Press, 1984: 203-258.
14. Mimnaugh MN, Gearien JE. Adrenergic drugs. In: Principles of medicinal chemistry, 3rd ed, Foye WO (eds), Philadelphia; Lea & Febiger, 1989: 343-358.
15. Jager PL, Vaalburg W, Pruim J, Vries E GE, Langen K-J, Piers DA. Radiolabeled amino acids: Basic aspects and clinical applications in oncology. J Nucl Med 2001; 42: 432-445.
16. Sekine T, Watanabe N, Hosoyamada M, Kanai Y, Endou H. Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 1997; 272: 18526-18529.
17. Shikano N, Kanai Y, Kawai K, Ishikawa N, Endou H. Transport of technetium-99m-MAG3 via rat renal organic anion transporter 1. J Nucl Med 2004; 45: 80-85.
18. 123I]iodo-L- α-methyl tyrosine transport in rat C6 glioma cells. Eur J Nucl Med 1999;26:1274-1278.
19. 123I]IMT) transport in human GOS3 glioma cells. Nucl Med Biol 2001; 28: 293-297.
20. 123I]IMT) transport into human Ewing's sarcoma cells in vitro. Nucl Med Biol 2001; 28: 123-128.
21. 125I]iodo-L-tyrosine into U266 human myeloma cells: Evidence for System T transport. Nucl Med Biol 2001; 28: 129-134.
22. Christensen HN. Role of amino acid transport and counter-transport in nutrition and metabolism. Physiol Rev 1990; 70: 43-77.
23. +-independent neutral amino acid transporter with broad substrate selectivity. J Biol Chem 1999; 274: 19745-19751.
24. Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H. Expression cloning and characterization of a transporter for large neutral amino acids activated by heavy chain of 4F2 antigen (CD98). J Biol Chem 1998; 273: 23629-23632.
25. 125I-iodo-α-methyl-L-tyrosine membrane transport in human L-type amino acid transporters. J Nucl Med 2003; 44: 244-246.
26. 125I]iodo-α-methyl-L-tyrosine transport via human L-type amino acid transporter 1. Nucl Med Biol 2003; 30: 31-37.